Low-dose remifentanil infusion does not impair natural killer cell function in healthy volunteers

A J Cronin1, N M Aucutt-Walter, T Budinetz

  • 1Penn State College of Medicine, Milton S Hershey Medical Center, 500 University Drive, H187, Hershey, PA 17033, USA. acronin@psu.edu

Abstract

Insights

Remifentanil infusion did not alter natural killer (NK) cell number or function in healthy volunteers. This contrasts with previous studies showing morphine and fentanyl affect NK cell activity.

Area of Science:

  • Immunology
  • Pharmacology
  • Anesthesiology

Background:

  • Mu opioid agonists are known to affect natural killer (NK) cell activity.
  • Previous studies in humans have shown conflicting results regarding opioid effects on NK cells, with morphine suppressing and fentanyl enhancing activity.

Purpose of the Study:

  • To evaluate the impact of a constant 8-hour infusion of remifentanil on NK cell number and function in healthy volunteers.

Main Methods:

  • Ten healthy volunteers received either a saline infusion or a remifentanil infusion (0.02-0.04 microg x kg(-1) min(-1)) for 8 hours.
  • Blood samples were collected to measure NK cell cytotoxicity using a (51)Cr release assay and NK cell number via fluorescent flow cytometry.

Main Results:

  • No significant changes were observed in NK cell number (cells/mL) or NK cell cytotoxicity (KU/mL) after remifentanil infusion compared to the control.
  • Specifically, neither the total NK cell cytotoxicity nor the cytotoxicity per 1000 NK cells differed between the control and remifentanil conditions.

Conclusions:

  • An 8-hour infusion of remifentanil does not affect NK cell number or function in healthy volunteers.
  • These findings differ from prior research indicating that other mu opioid agonists, like morphine and fentanyl, can alter NK cell activity.